Stocks · News reference
Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 11, 2026, 1:24 PM
- Checked
- Aug 11, 2026, 1:24 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Microbot Medical shares are trading lower after B. Riley Securities lowered its price target on the stock from $5 to $4.
Read original at benzingaB. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4
B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.
Read original at benzingaMicrobot Medical shares are trading lower after the company reported worse-than-expected Q2 sales results.
Read original at benzinga